Olema Pharmaceuticals (OLMA) Assets Average (2021 - 2026)

Olema Pharmaceuticals (OLMA) has 6 years of Assets Average data on file, last reported at $532.0 million in Q1 2026.

• Assets Average for Q1 2026 came in at $532.0 million, up 23.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $532.0 million (up 23.64% YoY), and the FY2025 annual result was $492.2 million, up 35.24% from the prior year.
• Assets Average grew to $532.0 million in Q1 2026 per OLMA's latest filing, from $442.9 million in the prior quarter.
• Over five years, Assets Average peaked at $532.0 million in Q1 2026 and troughed at $186.7 million in Q2 2023.
• A 5-year average of $306.4 million and a median of $270.3 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2023 and 2025: Assets Average declined 29.28% in 2023, then soared 59.19% in 2025.
• A 5-year view of Assets Average shows it stood at $223.8 million in 2022, then gained by 27.28% to $284.9 million in 2023, then advanced by 19.55% to $340.6 million in 2024, then jumped by 30.06% to $442.9 million in 2025, then gained by 20.11% to $532.0 million in 2026.
• Business Quant data shows OLMA's Assets Average at $532.0 million in Q1 2026, $442.9 million in Q4 2025, and $367.2 million in Q3 2025.